MetLife Investment Management, LLC

Position in CLPT — ClearPoint Neuro, Inc.

CIK 1529735 Whippany, NJ

Position in CLPT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$295,501

+$156,635 QoQ

Shares Held

16,564

+8.5% QoQ

Ownership

0.054%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#57

of 128 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $231,772,552 across 68 Medical Devices names. CLPT ranks #47 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	398,341	$36,145,462
2	SYK	Stryker Corp	78,948	$24,855,988
3	MDT	Medtronic plc	293,703	$22,976,385
4	BRKR	Bruker Corp	374,119	$22,514,481
5	GMED	Globus Medical Inc	275,556	$21,771,679
6	BSX	Boston Scientific Corp	339,986	$14,510,602
7	EW	Edwards Lifesciences Corp	131,633	$11,907,521
8	DXCM	Dexcom Inc	103,307	$6,957,726

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$295,501	16,564	+8.5%	Shares	Defined	2026-08-14
2026-03-31	$138,866	15,260	0.0%	Shares	Defined	2026-05-14
2025-12-31	$208,756	15,260	+35.5%	Shares	Defined	2026-02-12
2025-09-30	$245,311	11,258	-28.9%	Shares	Defined	2025-11-13
2025-06-30	$188,950	15,825	—	Shares	Defined	2025-08-13
2024-06-30	$0	0	-100.0%	Shares	Defined	2024-08-13
2024-03-31	$83,327	12,254	0.0%	Shares	Defined	2024-05-14
2023-12-31	$83,204	12,254	0.0%	Shares	Defined	2024-04-22
2023-09-30	$61,392	12,254	0.0%	Shares	Defined	2024-05-09
2023-06-30	$88,718	12,254	+58.7%	Shares	Defined	2024-04-29
2021-09-30	$137,047	7,721	0.0%	Shares	Defined	2024-05-17
2021-06-30	$147,393	7,721	—	Shares	Defined	2024-05-17
No filing history on record for this holder in this stock.